Skip to main content
Livermore
Livermore
ZHEN

FMR LLC

SEC CIK
0000315066
Latest filing
Aug 13, 2026

TERN holding history

Terns Pharmaceuticals, Inc. in every 13F filed by FMR LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TERN overviewAll 13F holders of TERNFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of TERN by FMR LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−295,622−100.0%Sold outHolders
Q1 2026295,622$15.6M<0.1%−731,241−71.2%ReducedHolders
Q4 20251,026,863$41.5M<0.1%+966,513+1,601.5%AddedHolders
Q3 202560,350$453.2K<0.1%+1,401+2.4%AddedHolders
Q2 202558,949$219.9K<0.1%+57,587+4,228.1%AddedHolders
Q1 20251,362$3.76K<0.1%−112,559−98.8%ReducedHolders
Q4 2024113,921$631.1K<0.1%−1,058,603−90.3%ReducedHolders
Q3 20241,172,524$9.78M<0.1%−1,594,572−57.6%ReducedHolders
Q2 20242,767,096$18.8M<0.1%+4,970+0.2%AddedHolders
Q1 20242,762,126$18.1M<0.1%−228,276−7.6%ReducedHolders
Q4 20232,990,402$19.4M<0.1%−2,127,648−41.6%ReducedHolders
Q3 20235,118,050$25.7M<0.1%−1,932,296−27.4%ReducedHolders
Q2 20237,050,346$61.7M<0.1%−592,412−7.8%ReducedHolders
Q1 20237,642,758$90.5M<0.1%+264,117+3.6%AddedHolders
Q4 20227,378,641$75.1M<0.1%+7,277,002+7,159.7%AddedHolders
Q3 2022101,639$599.0K<0.1%−360.0%ReducedHolders
Q2 2022101,675$252.0K<0.1%−2,219,783−95.6%ReducedHolders
Q1 20222,321,458$6.89M<0.1%−479,527−17.1%ReducedHolders
Q4 20212,800,985$19.8M<0.1%−132,177−4.5%ReducedHolders
Q3 20212,933,162$30.6M<0.1%−89,395−3.0%ReducedHolders
Q2 20213,022,557$37.1M<0.1%+134,819+4.7%AddedHolders
Q1 20212,887,738$63.5M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.